INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P908. A total of 7 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,791,430 | +494.1% | 204,500 | +254.4% | 0.00% | – |
| Q2 2023 | $638,162 | -54.3% | 57,700 | -44.5% | 0.00% | -100.0% |
| Q1 2023 | $1,396,720 | -53.0% | 104,000 | -56.7% | 0.00% | 0.0% |
| Q4 2022 | $2,970,037 | -45.4% | 240,100 | -38.4% | 0.00% | -50.0% |
| Q3 2022 | $5,438,000 | +139.8% | 389,800 | +137.4% | 0.00% | +100.0% |
| Q2 2022 | $2,268,000 | – | 164,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 189 | $905,000 | 0.06% |
| GROUP ONE TRADING, L.P. | 109,500 | $5,246,000 | 0.02% |
| SIMPLEX TRADING, LLC | 354 | $1,696,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |